secwatch.observer — SEC 8-K summary
======================================

Issuer:     CNS Pharmaceuticals, Inc. (CNSP)
CIK:        0001729427
Form:       8-K
Filed at:   2025-07-22T23:59:59+00:00
Accession:  0001683168-25-005284
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 3.03, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CNS Pharmaceuticals announces 1-for-12 reverse stock split effective July 22, 2025
--------------------------------------------------------------------------------

- Reverse split reduces outstanding shares from ~6.36M pre-split to ~529,829 post-split.
- Authorized common shares reduced from 300M to 25M; preferred from 5M to 416,667.
- No fractional shares; cash in lieu for odd lots.
- CUSIP changes to 18978H508; trading symbol CNSP unchanged.
- Historical per-share data recast: FY2024 basic loss per share goes from ($38.87) pre-split to ($466.43) post-split.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1729427/000168316825005284/0001683168-25-005284-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1729427/000168316825005284/cns_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-25-005284

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer